Nemaura Medical Company Description

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States.

It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients.

The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs.

Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Nemaura Medical Inc.

Country	United States
Founded	2009
Industry	Medical Devices
Sector	Healthcare
Employees	36
CEO	Dewan Fazlul Chowdhury

Contact Details

Address: 57 West 57th Street New York, Nevada 10019 United States
Phone	646 416 8000
Website	nemauramedical.com

Stock Details

Ticker Symbol	NMRD
Exchange	OTCMKTS
Fiscal Year	April - March
Reporting Currency	USD
ISIN Number	US6404422080
SIC Code	3845

Key Executives

Name	Position
Dr. Dewan Fazlul Hoque Chowdhury Ph.D.	Chairman, Interim Chief Financial Officer, Chief Executive Officer, President and Principal Financial and Accounting Officer
Jay L. Warner	Head of U.S. Commercial Operations
Thomas Bendix Mortensen	Head of E.U. Commercial Operations and Marketing
Samantha Sanders	Global Head of Digital Programs